Intermucol (Carbocisteine)

Carbocisteine acts by breaking disulfide bonds within mucopolysaccharide chains of mucus, which reduces its viscosity. The thinner mucus is more readily moved by ciliary action and coughing, facilitating clearance from the respiratory tract and reducing airway obstruction.

The dosage of Intermucol is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Patients should follow the prescriber’s instructions and the product labeling; no universal dosing regimen is provided here.

Safety data for carbocisteine during pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Intermucol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Compared with agents such as acetylcysteine, carbocisteine primarily reduces mucus viscosity by cleaving disulfide bonds rather than acting as a mucolytic antioxidant. It is generally well‑tolerated and available over‑the‑counter in many EU markets, offering an alternative for patients who need chronic mucus management.

Intermucol should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Intermucol is taken orally, usually with a glass of water. The tablet or liquid should be swallowed whole and not chewed, unless the product formulation specifically permits it. Administration should follow the prescriber’s directions regarding timing relative to meals.

Although uncommon, serious adverse reactions can include severe allergic responses such as rash, urticaria, angioedema, or anaphylaxis. Patients should seek immediate medical attention if they experience any signs of a hypersensitivity reaction, swelling of the face or throat, or difficulty breathing.

Intermucol should be avoided in individuals with a known hypersensitivity to carbocisteine or any of the excipients in the formulation. It is also contraindicated in patients who have experienced severe allergic reactions to mucolytic agents, and it should be used with caution in those with active peptic ulcer disease.